Comparative study of retinal nerve fiber layer measurement by StratusOCT and GDx VCC, II: Structure/function regression analysis in glaucoma

Investigative Ophthalmology and Visual Science

Volumn 46, Issue 10, 2005, Pages 3702-3711

  Leung, Christopher Kai Shun ^a   Chong, Kelvin Kam Long ^b   Chan, Wai Man ^b   Yiu, Cedric Ka Fai ^c   Tso, Man Yee ^a   Woo, Jackson ^a   Tsang, Moon Kwong ^a   Tse, Kwok Kay ^a   Yung, Wing Ho ^b  

^a Caritas Medical Centre Hong Kong   (Hong Kong)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DETERIORATION; DEVICE; DISEASE COURSE; EVALUATION; GLAUCOMA; HUMAN; LINEAR SYSTEM; MAJOR CLINICAL STUDY; MEASUREMENT; NONLINEAR SYSTEM; OPTICAL COHERENCE TOMOGRAPHY; PERIMETRY; PRIORITY JOURNAL; REGRESSION ANALYSIS; RETINA NERVE CELL; SCORING SYSTEM; THICKNESS; VISION; VISUAL FIELD; FEMALE; INTERFEROMETRY; LASER; MALE; METHODOLOGY; MIDDLE AGED; NERVE FIBER; PATHOLOGY; RETINA GANGLION CELL; VISUAL DISORDER;

DIAGNOSTIC AGENT;

DISEASE PROGRESSION; FEMALE; GLAUCOMA; HUMANS; INTERFEROMETRY; LASERS; MALE; MIDDLE AGED; NERVE FIBERS; PERIMETRY; REGRESSION ANALYSIS; RETINAL GANGLION CELLS; TOMOGRAPHY, OPTICAL COHERENCE; VISION DISORDERS; VISUAL FIELDS;

EID: 32944464155     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-0490     Document Type: Article

References (37)

1. Reus NJ, Lemij HG. The relationship between standard automated perimetry and GDx VCC measurements. Invest Ophthalmol Vis Sci. 2004;45:840-845.
2. El Beltagi TA, Bowd C, Boden C, et al. Retinal nerve fiber layer thickness measured with optical coherence tomography is related to visual function in glaucomatous eyes. Ophthalmology. 2003;110:2185-2191.
3. Lan YW, Henson DB, Kwartz AJ. The correlation between optic nerve head topographic measurements, peripapillary nerve fibre layer thickness, and visual field indices in glaucoma. Br J Ophthalmol. 2003;87:1135-1141.
4. Leung CK, Chan WM, YM Hui, et al. Analysis of retinal nerve fiber layer and optic nerve head in glaucoma with different reference plane offsets using optical coherence tomography. Invest Ophthalmol Vis Sci. 2005;46:891-899.
5. Schlottmann PG, De Cilla S, Greenfield DS, et al. Relationship between visual field sensitivity and retinal nerve fiber layer thickness as measured by scanning laser polarimetry. Invest Ophthalmol Vis Sci. 2004;45:1823-1829.
6. Smith SD, Katz J, Quigley HA. Analysis of progressive change in automated visual fields in glaucoma. Invest Ophthalmol Vis Sci. 1996;37:1419-1428.
7. Katz J, Gilbert D, Quigley HA, et al. Estimating progression of visual field loss in glaucoma. Ophthalmology. 1997;104:1017-1025.
8. Rasker MT, van den Enden A, Bakker D, et al. Rate of visual field loss in progressive glaucoma. Arch Ophthalmol. 2000;118:481-488.
9. Leske MC, Heijl A, Hussein M, et al. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003;121:48-56.
10. Chen PP, Park RJ. Visual field progression in patients with initially unilateral visual field loss from chronic open-angle glaucoma. Ophthalmology. 2000;107:1688-1692.
11. Martinez-Bello C, Chauhan BC, Nicolela MT, et al. Intraocular pressure and progression of glaucomatous visual field loss. Am J Ophthalmol. 2000;129:302-308.
12. Ishida K, Yamamoto T, Kitazawa Y. Clinical factors associated with progression of normal-tension glaucoma. J Glaucoma. 1998;7:372-377.
13. Advanced Glaucoma Intervention Study, 2: Visual field test scoring and reliability. Ophthalmology. 1994;101:1445-1455.
14. Musch DC, Lichter PR, Guire KE, et al. The Collaborative Initial Glaucoma Treatment Study: study design, methods, and baseline characteristics of enrolled patients. Ophthalmology. 1999;106:653-662.
15. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991;254:1178-1181.
16. Weinreb RN, Shakiba S, Zangwill L. Scanning laser polarimetry to measure the nerve fiber layer of normal and glaucomatous eyes. Am J Ophthalmol. 1995;119:627-636.
17. Burnham KP, Anderson DR. Information and likelihood theory: a basis for model selection and inference. In: Model Selection and Multimodal Inference: A Practical Information and Theoretic Approach. 2nd ed. New York: Springer; 2002;49-97.
18. Schuman JS, Pedut-Kloizman T, Hertzmark E, et al. Reproducibility of nerve fiber layer thickness measurements using optical coherence tomography. Ophthalmology. 1996;103:1889-1898.
19. Guedes V, Schuman JS, Hertzmark E, et al. Optical coherence tomography measurement of macular and nerve fiber layer thickness in normal and glaucomatous human eyes. Ophthalmology. 2003;110:177-189.
20. Varma R, Bazzaz S, Lai M. Optical tomography-measured retinal nerve fiber layer thickness in normal Latinos. Invest Ophthalmol Vis Sci. 2003;44:3369-3373.
21. Bowd C, Weinreb RN, Williams JM, et al. The retinal nerve fiber layer thickness in ocular hypertensive, normal, and glaucomatous eyes with optical coherence tomography. Arch Ophthalmol. 2000;118:22-26.
22. Kerrigan-Baumrind LA, Quigley HA, Pease ME, et al. Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Invest Ophthalmol Vis Sci. 2000;41:741-748.
23. Garway-Heath DF, Holder GE, Fitzke FW, et al. Relationship between electrophysiological, psychophysical, and anatomical measurements in glaucoma. Invest Ophthalmol Vis Sci. 2002;43:2213-2220.
24. Weinreb RN, Dreher AW, Coleman A, et al. Histopathologic validation of Fourier-ellipsometry measurements of retinal nerve fiber layer thickness. Arch Ophthalmol. 1990;108:557-560.
25. Huang XR, Bagga H, Greenfield DS, et al. Variation of peripapillary retinal nerve fiber layer birefringence in normal human subjects. Invest Ophthalmol Vis Sci. 2004;45:3073-3080.
26. Weber AJ, Kaufman PL, Hubbard WC. Morphology of single ganglion cells in the glaucomatous primate retina. Invest Ophthalmol Vis Sci. 1998;39:2304-2320.
27. Shou T, Liu J, Wang W, et al. Differential dendritic shrinkage of alpha and beta retinal ganglion cells in cats with chronic glaucoma. Invest Ophthalmol Vis Sci. 2003;44:3005-3010.
28. Harwerth RS, Carter-Dawson L, Shen F, et al. Ganglion cell losses underlying visual field defects from experimental glaucoma. Invest Ophthalmol Vis Sci. 1999:40:2242-2250.
29. Harwerth RS, Crawford ML, Frishman LJ, et al. Visual field defects and neural losses from experimental glaucoma. Prog Retin Eye Res. 2002;21:91-125.
30. Lichter PR, Musch DC, Gillespie BW, et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108:1943-1953.
31. Nouri-Mahdavi K, Hoffman D, Coleman AL, et al. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology. 2004;111:1627-1635.
32. Wilson R, Walker AM, Dueker DK, et al. Risk factors for rate of progression of glaucomatous visual field loss: a computer-based analysis. Arch Ophthalmol. 1982;100:737-74l.
33. O'Brien C, Schwartz B, Takamoto T, et al. Intraocular pressure and the rate of visual field loss in chronic open-angle glaucoma. Am J Ophthalmol. 1991;111:491-500.
34. Schwartz B, Takamoto T, Martin J. Increased rate of visual field loss associated with larger initial visual field threshold values on follow-up of open-angle glaucoma. J Glaucoma. 2004;13:120-129.
35. Katz J. Scoring systems for measuring progression of visual field loss in clinical trials of glaucoma treatment. Ophthalmology. 1999;106:391-395.
36. Kim J, Dally LG, Ederer F, et al. The Advanced Glaucoma Intervention Study (AGIS), 14: distinguishing progression of glaucoma from visual field fluctuations. Ophthalmology. 2004;111:2109-2116.
37. Vesti E, Johnson CA, Chauhan BC. Comparison of different methods for detecting glaucomatous visual field progression. Invest Ophthalmol Vis Sci. 2003;44:3873-3879.